— Know what they know.
Not Investment Advice

EXAI NASDAQ

Exscientia plc
1W: -13.7% 1M: -4.2% 3M: -14.8% 1Y: -16.8% 3Y: -77.2%
$4.84
Last traded 2024-11-20 — delisted
NASDAQ · Healthcare · Biotechnology · $633.2M mcap · 84M float · 0.840% daily turnover

Balance Sheet Trends

Total Assets
$511M -21.4% ▼
4Y CAGR: +75.1%
Total Liabilities
$155M -9.2% ▼
4Y CAGR: +57.1%
Shareholders Equity
$359M -25.1% ▼
4Y CAGR: +87.7%
Cash & Investments
$363M -28.1% ▼
4Y CAGR: +72.2%
Total Debt
$19M +36.2% ▲
4Y CAGR: +89.8%
Net Debt
-$239M +38.8% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$41M$82M$417M$404M$258M
Short-Term Investments$0$0$0$101M$104M
Cash & ST Investments$41M$82M$417M$505M$363M
Net Receivables$2M$689K$2M$42M$9M
Inventory-$7K$3M$359K$50K$0
Other Current Assets$0$4M$15M$860K$33M
Total Current Assets$49M$94M$582M$554M$405M
Property, Plant & Equip.$4M$11M$14M$52M$67M
Goodwill & Intangibles$435K$425K$42M$40M$35M
Long-Term Investments$472K$168K$3M$2M$2M
Other Non-Current Assets$0$0$100K$100K$1M
Total Non-Current Assets$5M$12M$59M$96M$106M
Total Assets$54M$106M$475M$650M$511M
— Liabilities —
Accounts Payable$2M$3M$6M$31M$11M
Short-Term Debt$0$0$0$0$0
Deferred Revenue$16M$12M$30M$39M$0
Other Current Liabilities-$185K-$255K-$2M$0$29M
Total Current Liabilities$21M$20M$46M$92M$65M
Long-Term Debt$0$0$296K$313K$306K
Other Non-Current Liab.$1M$3M$24M$2M$73M
Total Non-Current Liabilities$4M$6M$28M$79M$90M
Total Liabilities$25M$26M$55M$171M$155M
— Equity —
Common Stock$0$0$60K$61K$63K
Retained Earnings-$16M-$46M$136M$23M-$110M
Accumulated OCI-$10K-$151K$53M$56M$101M
Total Stockholders Equity$29M$80M$420M$479M$359M
Total Liabilities & Equity$54M$106M$475M$650M$511M
— Key Metrics —
Total Debt$1M$5M$5M$14M$19M
Net Debt-$40M-$78M-$412M-$390M-$239M
Total Investments$472K$168K$3M$103M$106M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms